Mapping of a molecular determinant for protein kinase C β(II) isozyme function

Yesim Gökmen-Polar, Alan P Fields

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

In human erythroleukemia (K562) cells, the highly related protein kinase C (PKC) α and PKC β(II) isozymes serve distinct functions in cellular differentiation and proliferation, respectively. Previous studies using two domain switch PKC chimera revealed that the Catalytic domains of PKC α and β(II) contain molecular determinants important for isozyme-specific function (Walker, S. D., Murray, N. R., Burns, D. J., and Fields, A. P. (1995) Proc. Natl. Acad. Sci. U.S.A. 92, 9156-9160). We have now analyzed a panel of PKC chimeras to determine the specific region within the catalytic domain important for PKC β(II) function. A cellular assay for PKC β(II) function was devised based on the finding that PKC β(II) selectively translocates to the nucleus and phosphorylates nuclear lamin B in response to the PKC activator bryostatin. This response is strictly dependent upon expression of PKC β(II) or a PKC chimera that functions like PKC β(II). We demonstrate that a PKC α/β(II) chimera containing only the carboxyl-terminal 13 amino acids from PKC β(II) (β(II) V5) is capable of nuclear translocation and lamin B phosphorylation. These results are consistent with our recent observation that the PKC β(II) V5 region binds to phosphatidylglycerol (PG), a potent and selective PKC β(II) activator present in the nuclear membrane (Murray, N. R., and Fields, A. P. (1998) J. Biol. Chem. 273, 11514-11520). Soluble β(II) V5 peptide selectively inhibits PG-stimulated PKC β(II) activity in a dose-dependent fashion, indicating that PG-mediated activation of PKC β(II) involves interactions with the β(II) V5 region of the enzyme. We conclude that β(II) V5 is a major determinant for PKC β(II) nuclear function and suggest a model in which binding of PG to the β(II) V5 region stimulates nuclear PKC β(II) activity during G2 phase of the cell cycle.

Original languageEnglish (US)
Pages (from-to)20261-20266
Number of pages6
JournalJournal of Biological Chemistry
Volume273
Issue number32
DOIs
StatePublished - Aug 7 1998
Externally publishedYes

Fingerprint

Protein Kinase C
Isoenzymes
Phosphatidylglycerols
Lamin Type B
Catalytic Domain
Bryostatins
Leukemia, Erythroblastic, Acute
Phosphorylation
K562 Cells
G2 Phase
Nuclear Envelope
Nuclear Proteins

ASJC Scopus subject areas

  • Biochemistry

Cite this

Mapping of a molecular determinant for protein kinase C β(II) isozyme function. / Gökmen-Polar, Yesim; Fields, Alan P.

In: Journal of Biological Chemistry, Vol. 273, No. 32, 07.08.1998, p. 20261-20266.

Research output: Contribution to journalArticle

@article{56d4e7845eba4b2398103615723c018d,
title = "Mapping of a molecular determinant for protein kinase C β(II) isozyme function",
abstract = "In human erythroleukemia (K562) cells, the highly related protein kinase C (PKC) α and PKC β(II) isozymes serve distinct functions in cellular differentiation and proliferation, respectively. Previous studies using two domain switch PKC chimera revealed that the Catalytic domains of PKC α and β(II) contain molecular determinants important for isozyme-specific function (Walker, S. D., Murray, N. R., Burns, D. J., and Fields, A. P. (1995) Proc. Natl. Acad. Sci. U.S.A. 92, 9156-9160). We have now analyzed a panel of PKC chimeras to determine the specific region within the catalytic domain important for PKC β(II) function. A cellular assay for PKC β(II) function was devised based on the finding that PKC β(II) selectively translocates to the nucleus and phosphorylates nuclear lamin B in response to the PKC activator bryostatin. This response is strictly dependent upon expression of PKC β(II) or a PKC chimera that functions like PKC β(II). We demonstrate that a PKC α/β(II) chimera containing only the carboxyl-terminal 13 amino acids from PKC β(II) (β(II) V5) is capable of nuclear translocation and lamin B phosphorylation. These results are consistent with our recent observation that the PKC β(II) V5 region binds to phosphatidylglycerol (PG), a potent and selective PKC β(II) activator present in the nuclear membrane (Murray, N. R., and Fields, A. P. (1998) J. Biol. Chem. 273, 11514-11520). Soluble β(II) V5 peptide selectively inhibits PG-stimulated PKC β(II) activity in a dose-dependent fashion, indicating that PG-mediated activation of PKC β(II) involves interactions with the β(II) V5 region of the enzyme. We conclude that β(II) V5 is a major determinant for PKC β(II) nuclear function and suggest a model in which binding of PG to the β(II) V5 region stimulates nuclear PKC β(II) activity during G2 phase of the cell cycle.",
author = "Yesim G{\"o}kmen-Polar and Fields, {Alan P}",
year = "1998",
month = "8",
day = "7",
doi = "10.1074/jbc.273.32.20261",
language = "English (US)",
volume = "273",
pages = "20261--20266",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "32",

}

TY - JOUR

T1 - Mapping of a molecular determinant for protein kinase C β(II) isozyme function

AU - Gökmen-Polar, Yesim

AU - Fields, Alan P

PY - 1998/8/7

Y1 - 1998/8/7

N2 - In human erythroleukemia (K562) cells, the highly related protein kinase C (PKC) α and PKC β(II) isozymes serve distinct functions in cellular differentiation and proliferation, respectively. Previous studies using two domain switch PKC chimera revealed that the Catalytic domains of PKC α and β(II) contain molecular determinants important for isozyme-specific function (Walker, S. D., Murray, N. R., Burns, D. J., and Fields, A. P. (1995) Proc. Natl. Acad. Sci. U.S.A. 92, 9156-9160). We have now analyzed a panel of PKC chimeras to determine the specific region within the catalytic domain important for PKC β(II) function. A cellular assay for PKC β(II) function was devised based on the finding that PKC β(II) selectively translocates to the nucleus and phosphorylates nuclear lamin B in response to the PKC activator bryostatin. This response is strictly dependent upon expression of PKC β(II) or a PKC chimera that functions like PKC β(II). We demonstrate that a PKC α/β(II) chimera containing only the carboxyl-terminal 13 amino acids from PKC β(II) (β(II) V5) is capable of nuclear translocation and lamin B phosphorylation. These results are consistent with our recent observation that the PKC β(II) V5 region binds to phosphatidylglycerol (PG), a potent and selective PKC β(II) activator present in the nuclear membrane (Murray, N. R., and Fields, A. P. (1998) J. Biol. Chem. 273, 11514-11520). Soluble β(II) V5 peptide selectively inhibits PG-stimulated PKC β(II) activity in a dose-dependent fashion, indicating that PG-mediated activation of PKC β(II) involves interactions with the β(II) V5 region of the enzyme. We conclude that β(II) V5 is a major determinant for PKC β(II) nuclear function and suggest a model in which binding of PG to the β(II) V5 region stimulates nuclear PKC β(II) activity during G2 phase of the cell cycle.

AB - In human erythroleukemia (K562) cells, the highly related protein kinase C (PKC) α and PKC β(II) isozymes serve distinct functions in cellular differentiation and proliferation, respectively. Previous studies using two domain switch PKC chimera revealed that the Catalytic domains of PKC α and β(II) contain molecular determinants important for isozyme-specific function (Walker, S. D., Murray, N. R., Burns, D. J., and Fields, A. P. (1995) Proc. Natl. Acad. Sci. U.S.A. 92, 9156-9160). We have now analyzed a panel of PKC chimeras to determine the specific region within the catalytic domain important for PKC β(II) function. A cellular assay for PKC β(II) function was devised based on the finding that PKC β(II) selectively translocates to the nucleus and phosphorylates nuclear lamin B in response to the PKC activator bryostatin. This response is strictly dependent upon expression of PKC β(II) or a PKC chimera that functions like PKC β(II). We demonstrate that a PKC α/β(II) chimera containing only the carboxyl-terminal 13 amino acids from PKC β(II) (β(II) V5) is capable of nuclear translocation and lamin B phosphorylation. These results are consistent with our recent observation that the PKC β(II) V5 region binds to phosphatidylglycerol (PG), a potent and selective PKC β(II) activator present in the nuclear membrane (Murray, N. R., and Fields, A. P. (1998) J. Biol. Chem. 273, 11514-11520). Soluble β(II) V5 peptide selectively inhibits PG-stimulated PKC β(II) activity in a dose-dependent fashion, indicating that PG-mediated activation of PKC β(II) involves interactions with the β(II) V5 region of the enzyme. We conclude that β(II) V5 is a major determinant for PKC β(II) nuclear function and suggest a model in which binding of PG to the β(II) V5 region stimulates nuclear PKC β(II) activity during G2 phase of the cell cycle.

UR - http://www.scopus.com/inward/record.url?scp=0032493823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032493823&partnerID=8YFLogxK

U2 - 10.1074/jbc.273.32.20261

DO - 10.1074/jbc.273.32.20261

M3 - Article

VL - 273

SP - 20261

EP - 20266

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 32

ER -